Legionfarm, pairing pro gamers with amateurs, raises $6 million Series A
15 May, 2021
– Ronovo Surgical, an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery to address the tremendous needs of the Chinese surgical market, recently announced successful closing of Series A financing.
– The Series A financing was co-led by Matrix Partners China and Vivo Capital, with strong, continued support from seed investor Lilly Asia Ventures (LAV) and participation from GGV Capital.
– Developed by renowned surgeons, medtech veterans and robotics experts, Ronovo was founded in Shanghai in 2019 to establish a transformative technology platform that democratizes MIS and digital surgery in the vastly underserved Chinese surgical market.
– By focusing on the three pillars of simplicity, precision, and intelligence, Ronovo is positioning itself as a gateway to China for cutting edge MIS and digital surgery technology companies from around the world.